Synonym:
Fastic,
N-[(trans-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine,
Starlix,
Starsis
Properties:
Related Categories |
Analytical Standards,
Analytical/Chromatography,
EP Standards,
EP Standards N - O,
Pharmacopeia & Metrological Institutes Standards
|
Description:
Caution
Please find SDS provided by EDQM here..
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Biochem/physiol Actions
Nateglinide is a Kir6.2/SUR1 channel inhibitor and antidiabetic. It is selective for the SUR1 subtype, which is found on pancreatic islet cells. Nateglinide evokes KATP channel-dependent insulin secretion (50-200 μM) in the absence and presence of insulin.
Safety:
RIDADR
NONH for all modes of transport